300 related articles for article (PubMed ID: 10861276)
1. Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals.
Khakoo SI; Ling R; Scott I; Dodi AI; Harrison TJ; Dusheiko GM; Madrigal JA
Gut; 2000 Jul; 47(1):137-43. PubMed ID: 10861276
[TBL] [Abstract][Full Text] [Related]
2. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis.
Missale G; Redeker A; Person J; Fowler P; Guilhot S; Schlicht HJ; Ferrari C; Chisari FV
J Exp Med; 1993 Mar; 177(3):751-62. PubMed ID: 7679709
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.
Bertoletti A; Costanzo A; Chisari FV; Levrero M; Artini M; Sette A; Penna A; Giuberti T; Fiaccadori F; Ferrari C
J Exp Med; 1994 Sep; 180(3):933-43. PubMed ID: 7520476
[TBL] [Abstract][Full Text] [Related]
4. [Detection of antigen-epitope-specific cytotoxic T lymphocytes in patients with hepatitis B virus infection by enzyme linked immunospot assay].
Zhang HP; Yan HP; Zhang YH; Feng X; Zhao Y; Liao HY; Liu YM; Chen Y; Tan YF; Liu Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Aug; 43(8):690-4. PubMed ID: 20021848
[TBL] [Abstract][Full Text] [Related]
5. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
[TBL] [Abstract][Full Text] [Related]
6. CD8
Zhang Y; Wu Y; Deng M; Xu D; Li X; Xu Z; Hu J; Zhang H; Liu K; Zhao Y; Gao F; Bi S; Gao GF; Zhao J; Liu WJ; Meng S
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950410
[TBL] [Abstract][Full Text] [Related]
7. High frequency of functional anti-YMDD and -mutant cytotoxic T lymphocytes after in vitro expansion correlates with successful response to lamivudine therapy for chronic hepatitis B.
Lin CL; Tsai SL; Lee TH; Chien RN; Liao SK; Liaw YF
Gut; 2005 Jan; 54(1):152-61. PubMed ID: 15591521
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic T lymphocyte activity to hepatitis B virus DNA-transfected HepG2 cells in patients with chronic hepatitis B.
Ito Y; Kakumu S; Yoshioka K; Wakita T; Ishikawa T; Koike K
Gastroenterol Jpn; 1993 Oct; 28(5):657-65. PubMed ID: 7693538
[TBL] [Abstract][Full Text] [Related]
9. CTL escape mutations of core protein are more frequent in strains of HBeAg negative patients with low levels of HBV DNA.
Sendi H; Mehrab-Mohseni M; Shahraz S; Norder H; Alavian SM; Noorinayer B; Zali MR; Pumpens P; Bonkovsky HL; Magnius LO
J Clin Virol; 2009 Nov; 46(3):259-64. PubMed ID: 19748824
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen.
Penna A; Chisari FV; Bertoletti A; Missale G; Fowler P; Giuberti T; Fiaccadori F; Ferrari C
J Exp Med; 1991 Dec; 174(6):1565-70. PubMed ID: 1720813
[TBL] [Abstract][Full Text] [Related]
11. Genetic immunization of chimpanzees chronically infected with the hepatitis B virus, using a recombinant retroviral vector encoding the hepatitis B virus core antigen.
Sällberg M; Hughes J; Javadian A; Ronlov G; Hultgren C; Townsend K; Anderson CG; O'Dea J; Alfonso J; Eason R; Murthy KK; Jolly DJ; Chang SM; Mento SJ; Milich D; Lee WT
Hum Gene Ther; 1998 Aug; 9(12):1719-29. PubMed ID: 9721082
[TBL] [Abstract][Full Text] [Related]
12. DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes.
Kuhröber A; Wild J; Pudollek HP; Chisari FV; Reimann J
Int Immunol; 1997 Aug; 9(8):1203-12. PubMed ID: 9263018
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899 T Cell Vaccine Study Group.
Heathcote J; McHutchison J; Lee S; Tong M; Benner K; Minuk G; Wright T; Fikes J; Livingston B; Sette A; Chestnut R
Hepatology; 1999 Aug; 30(2):531-6. PubMed ID: 10421664
[TBL] [Abstract][Full Text] [Related]
14. The high prevalence of the I27 mutant HBcAg18-27 epitope in Chinese HBV-infected patients and its cross-reactivity with the V27 prototype epitope.
Liu HG; Chen WW; Fan ZP; Yang HY; Shi M; Zhang Z; Luan SS; Zhang H; Lu P; Tien P; Wang FS
Clin Immunol; 2007 Dec; 125(3):337-45. PubMed ID: 17900990
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus surface protein mutations clustered mainly in CTL immune epitopes in chronic carriers: results of an Iranian nationwide study.
Khedive A; Norouzi M; Ramezani F; Karimzadeh H; Alavian SM; Malekzadeh R; Montazeri G; Nejatizadeh A; Ziaee M; Abedi F; Ataei B; Yaran M; Sayad B; Somi MH; Sarizadeh G; Sanei-Moghaddam I; Mansour-Ghanaei F; Rafatpanah H; Pourhosseingholi MA; Keyvani H; Kalantari E; Saberifiroozi M; Judaki MA; Ghamari S; Daram M; Mahabadi M; Fazeli Z; Goodarzi Z; Poortahmasebi V; Jazayeri SM
J Viral Hepat; 2013 Jul; 20(7):494-501. PubMed ID: 23730843
[TBL] [Abstract][Full Text] [Related]
16. Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization.
Loirat D; Lemonnier FA; Michel ML
J Immunol; 2000 Oct; 165(8):4748-55. PubMed ID: 11035120
[TBL] [Abstract][Full Text] [Related]
17. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes.
Sijts AJ; Ruppert T; Rehermann B; Schmidt M; Koszinowski U; Kloetzel PM
J Exp Med; 2000 Feb; 191(3):503-14. PubMed ID: 10662796
[TBL] [Abstract][Full Text] [Related]
18. Identification of HLA-A*0201-restricted CD8+ T-cell epitope C₆₄₋₇₂ from hepatitis B virus core protein.
Liu Q; Zheng Y; Yu Y; Tan Q; Huang X
Int Immunopharmacol; 2012 Jun; 13(2):141-7. PubMed ID: 22480777
[TBL] [Abstract][Full Text] [Related]
19. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
[TBL] [Abstract][Full Text] [Related]
20. TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.
Wang H; Luo H; Wan X; Fu X; Mao Q; Xiang X; Zhou Y; He W; Zhang J; Guo Y; Tan W; Deng G
J Hepatol; 2020 Jan; 72(1):45-56. PubMed ID: 31499130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
